Role of N-linked glycosylation of the human parainfluenza virus type 3 hemagglutinin-neuraminidase protein

Virus Research

Volumn 174, Issue 1-2, 2013, Pages 137-147

  Chu, Fu lu ^a   Wen, Hong ling ^a   Hou, Gui hua ^a   Lin, Bin ^b   Zhang, Wen qiang ^b   Song, Yan yan ^a   Ren, Gui jie ^a   Sun, Cheng xi ^a   Li, Zhen mei ^a   Wang, Zhiyu ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Hemagglutinin neuraminidase protein; Hemagglutinin neuraminidase fusion protein complexes; Human parainfluenza virus type 3; Membrane fusion; Mutations; N linked glycosylation sites

Indexed keywords

CARBOHYDRATE; GLYCAN; HN PROTEIN; MUTANT PROTEIN; PROTEIN ANTIBODY; VIRUS SIALIDASE;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CELL LYSATE; CELL SURFACE; CELL TRANSPORT; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; ENZYME ACTIVITY; GENE MUTATION; GLYCOSYLATION; HEMADSORPTION; IMMUNOPRECIPITATION; MUTANT; NONHUMAN; PARAINFLUENZA VIRUS 3; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN INTERACTION; WILD TYPE;

DNA MUTATIONAL ANALYSIS; GLYCOSYLATION; HN PROTEIN; HUMANS; MUTAGENESIS, SITE-DIRECTED; MUTANT PROTEINS; PARAINFLUENZA VIRUS 3, HUMAN; PROTEIN PROCESSING, POST-TRANSLATIONAL; VIRUS INTERNALIZATION;

HUMAN PARAINFLUENZA VIRUS 3;

EID: 84877595007     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2013.03.012     Document Type: Article

References (47)

1. Abe Y., Takashita E., Sugawara K., Matsuzaki Y., Muraki Y., Hongo S. Effect of the addition of oligosaccharides on the biological activities and antigenicity of influenza A/H3N2 virus hemagglutinin. Journal of Virology 2004, 78(18):9605-9611.
2. Aguilar H.C., Matreyek K.A., Filone C.M., Hashimi S.T., Levroney E.L., Negrete O.A., Bertolotti-Ciarlet A., Choi D.Y., McHardy I., Fulcher J.A., Su S.V., Wolf M.C., Kohatsu L., Baum L.G., Lee B. N-glycans on Nipah virus fusion protein protect against neutralization but reduce membrane fusion and viral entry. Journal of Virology 2006, 80(10):4878-4889.
3. Aminoff D. Methods for the quantitative estimation of N-acetylneuraminic acid and their application to hydrolysates of sialomucoids. Biochemical Journal 1961, 81:384-392.
4. Bagai S., Lamb R.A. Quantitative measurement of paramyxovirus fusion: differences in requirements of glycoproteins between simian virus 5 and human parainfluenza virus 3 or Newcastle disease virus. Journal of Virology 1995, 69(11):6712-6719.
5. Bose S., Basu M., Banerjee A.K. Role of nucleolin in human parainfluenza virus type 3 infection of human lung epithelial cells. Journal of Virology 2004, 78(15):8146-8158.
6. Carter J.R., Pager C.T., Fowler S.D., Dutch R.E. Role of N-linked glycosylation of the Hendra virus fusion protein. Journal of Virology 2005, 79(12):7922-7925.
7. Chu F.-L., Wen H.-L., Zhang W.-Q., Lin B., Zhang Y., Sun C.-X., Ren G.-J., Song Y.-Y., Wang Z. 'a'-position-mutated and G4-mutated hemagglutinin-neuraminidase proteins of Newcastle disease virus impair fusion and hemagglutinin-neuraminidase-fusion interaction by different mechanisms. Intervirology 2013, 56(1):27-36.
8. Corey E.A., Iorio R.M. Mutations in the stalk of the measles virus hemagglutinin protein decrease fusion but do not interfere with virus-specific interaction with the homologous fusion protein. Journal of Virology 2007, 81(18):9900-9910.
9. Dolganiuc V., McGinnes L., Luna E.J., Morrison T.G. Role of the cytoplasmic domain of the Newcastle disease virus fusion protein in association with lipid rafts. Journal of Virology 2003, 77(24):12968-12979.
10. Durbin A.P., Hall S.L., Siew J.W., Whitehead S.S., Collins P.L., Murphy B.R. Recovery of infectious human parainfluenza virus type 3 from cDNA. Virology 1997, 235(2):323-332.
11. Dutch R.E., Joshi S.B., Lamb R.A. Membrane fusion promoted by increasing surface densities of the paramyxovirus F and HN proteins: comparison of fusion reactions mediated by simian virus 5 F, human parainfluenza virus type 3 F, and influenza virus HA. Journal of Virology 1998, 72(10):7745-7753.
12. Elango N., Coligan J.E., Jambou R.C., Venkatesan S. Human parainfluenza type 3 virus hemagglutinin-neuraminidase glycoprotein: nucleotide sequence of mRNA and limited amino acid sequence of the purified protein. Journal of Virology 1986, 57(2):481-489.
13. Erickson B.R., Deyde V., Sanchez A.J., Vincent M.J., Nichol S.T. N-linked glycosylation of Gn (but not Gc) is important for Crimean Congo hemorrhagic fever virus glycoprotein localization and transport. Virology 2007, 361(2):348-355.
14. Fry A.M., Curns A.T., Harbour K., Hutwagner L., Holman R.C., Anderson L.J. Seasonal trends of human parainfluenza viral infections: United States, 1990-2004. Clinical Infectious Diseases 2006, 43(8):1016-1022.
15. Helle F., Vieyres G., Elkrief L., Popescu C.I., Wychowski C., Descamps V., Castelain S., Roingeard P., Duverlie G., Dubuisson J. Role of N-linked glycans in the functions of hepatitis C virus envelope proteins incorporated into infectious virions. Journal of Virology 2010, 84(22):11905-11915.
16. Horga M.A., Gusella G.L., Greengard O., Poltoratskaia N., Porotto M., Moscona A. Mechanism of interference mediated by human parainfluenza virus type 3 infection. Journal of Virology 2000, 74(24):11792-11799.
17. Hu X.L., Ray R., Compans R.W. Functional interactions between the fusion protein and hemagglutinin-neuraminidase of human parainfluenza viruses. Journal of Virology 1992, 66(3):1529-1534.
18. Jung C., Le Doux J.M. Lentiviruses inefficiently incorporate human parainfluenza type 3 envelope proteins. Biotechnology and Bioengineering 2008, 99(4):1016-1027.
19. Kim J.M., Yun S.I., Song B.H., Hahn Y.S., Lee C.H., Oh H.W., Lee Y.M. A single N-linked glycosylation site in the Japanese encephalitis virus prM protein is critical for cell type-specific prM protein biogenesis, virus particle release, and pathogenicity in mice. Journal of Virology 2008, 82(16):7846-7862.
20. Lawrence M.C., Borg N.A., Streltsov V.A., Pilling P.A., Epa V.C., Varghese J.N., McKimm-Breschkin J.L., Colman P.M. Structure of the haemagglutinin-neuraminidase from human parainfluenza virus type III. Journal of Molecular Biology 2004, 335(5):1343-1357.
21. Lee M.S., Greenberg D.P., Yeh S.H., Yogev R., Reisinger K.S., Ward J.I., Blatter M.M., Cho I., Holmes S.J., Cordova J.M., August M.J., Chen W., Mehta H.B., Coelingh K.L., Mendelman P.M. Antibody responses to bovine parainfluenza virus type 3 (PIV3) vaccination and human PIV3 infection in young infants. Journal of Infectious Diseases 2001, 184(7):909-913.
22. Levroney E.L., Aguilar H.C., Fulcher J.A., Kohatsu L., Pace K.E., Pang M., Gurney K.B., Baum L.G., Lee B. Novel innate immune functions for galectin-1: galectin-1 inhibits cell fusion by Nipah virus envelope glycoproteins and augments dendritic cell secretion of proinflammatory cytokines. Journal of Immunology 2005, 175(1):413-420.
23. Li J., Quinlan E., Mirza A., Iorio R.M. Mutated form of the Newcastle disease virus hemagglutinin-neuraminidase interacts with the homologous fusion protein despite deficiencies in both receptor recognition and fusion promotion. Journal of Virology 2004, 78(10):5299-5310.
24. McGinnes L.W., Morrison T.G. The role of individual oligosaccharide chains in the activities of the HN glycoprotein of Newcastle disease virus. Virology 1995, 212(2):398-410.
25. Melanson V.R., Iorio R.M. Amino acid substitutions in the F-specific domain in the stalk of the Newcastle disease virus HN protein modulate fusion and interfere with its interaction with the F protein. Journal of Virology 2004, 78(23):13053-13061.
26. Melanson V.R., Iorio R.M. Addition of N-glycans in the stalk of the Newcastle disease virus HN protein blocks its interaction with the F protein and prevents fusion. Journal of Virology 2006, 80(2):623-633.
27. Mishin V.P., Watanabe M., Taylor G., DeVincenzo J., Bose M., Portner A., Alymova I.V. N-Linked Glycan at residue 523 of human parainfluenza virus type 3 hemagglutinin-neuraminidase masks a second receptor-binding site. Journal of Virology 2010, 84(6):3094-3100.
28. Morris S.J., Sarkar D.P., White J.M., Blumenthal R. Kinetics of pH-dependent fusion between 3T3 fibroblasts expressing influenza hemagglutinin and red blood cells. measurement by dequenching of fluorescence. Journal of Biological Chemistry 1989, 264(7):3972-3978.
29. Moscona A. Entry of parainfluenza virus into cells as a target for interrupting childhood respiratory disease. Journal of Clinical Investigation 2005, 115(7):1688-1698.
30. Moscona A., Peluso R.W. Fusion properties of cells persistently infected with human parainfluenza virus type 3: participation of hemagglutinin-neuraminidase in membrane fusion. Journal of Virology 1991, 65(6):2773-2777.
31. Moscona A., Peluso R.W. Relative affinity of the human parainfluenza virus type 3 hemagglutinin-neuraminidase for sialic acid correlates with virus-induced fusion activity. Journal of Virology 1993, 67(11):6463-6468.
32. Ng D.T., Hiebert S.W., Lamb R.A. Different roles of individual N-linked oligosaccharide chains in folding, assembly, and transport of the simian virus 5 hemagglutinin-neuraminidase. Molecular and Cellular Biology 1990, 10(5):1989-2001.
33. Palermo L.M., Porotto M., Greengard O., Moscona A. Fusion promotion by a paramyxovirus hemagglutinin-neuraminidase protein: pH modulation of receptor avidity of binding sites I and II. Journal of Virology 2007, 81(17):9152-9161.
34. Panda A., Elankumaran S., Krishnamurthy S., Huang Z., Samal S.K. Loss of N-linked glycosylation from the hemagglutinin-neuraminidase protein alters virulence of Newcastle disease virus. Journal of Virology 2004, 78(10):4965-4975.
35. Porotto M., Murrell M., Greengard O., Lawrence M.C., McKimm-Breschkin J.L., Moscona A. Inhibition of parainfluenza virus type 3 and Newcastle disease virus hemagglutinin-neuraminidase receptor binding: effect of receptor avidity and steric hindrance at the inhibitor binding sites. Journal of Virology 2004, 78(24):13911-13919.
36. Porotto M., Palmer S.G., Palermo L.M., Moscona A. Mechanism of fusion triggering by human parainfluenza virus type III: communication between viral glycoproteins during entry. Journal of Biological Chemistry 2011, 287(1):778-793.
37. Reed G., Jewett P.H., Thompson J., Tollefson S., Wright P.F. Epidemiology and clinical impact of parainfluenza virus infections in otherwise healthy infants and young children <5years old. Journal of Infectious Diseases 1997, 175(4):807-813.
38. Risatti G.R., Holinka L.G., Fernandez Sainz I., Carrillo C., Lu Z., Borca M.V. N-linked glycosylation status of classical swine fever virus strain Brescia E2 glycoprotein influences virulence in swine. Journal of Virology 2007, 81(2):924-933.
39. Shakin-Eshleman S.H., Remaley A.T., Eshleman J.R., Wunner W.H., Spitalnik S.L. N-linked glycosylation of rabies virus glycoprotein. Individual sequons differ in their glycosylation efficiencies and influence on cell surface expression. Journal of Biological Chemistry 1992, 267(15):10690-10698.
40. Shi X., Brauburger K., Elliott R.M. Role of N-linked glycans on Bunyamwera virus glycoproteins in intracellular trafficking, protein folding, and virus infectivity. Journal of Virology 2005, 79(21):13725-13734.
41. Takimoto T., Taylor G.L., Connaris H.C., Crennell S.J., Portner A. Role of the hemagglutinin-neuraminidase protein in the mechanism of Paramyxovirus-cell membrane fusion. Journal of Virology 2002, 76(24):13028-13033.
42. Tanaka Y., Kato J., Kohara M., Galinski M.S. Antiviral effects of glycosylation and glucose trimming inhibitors on human parainfluenza virus type 3. Antiviral Research 2006, 72(1):1-9.
43. van Gils M.J., Bunnik E.M., Boeser-Nunnink B.D., Burger J.A., Terlouw-Klein M., Verwer N., Schuitemaker H. Longer V1V2 region with increased number of potential N-linked glycosylation sites in the HIV-1 envelope glycoprotein protects against HIV-specific neutralizing antibodies. Journal of Virology 2011, 85(14):6986-6995.
44. Wang C.C., Chen J.R., Tseng Y.C., Hsu C.H., Hung Y.F., Chen S.W., Chen C.M., Khoo K.H., Cheng T.J., Cheng Y.S.E., Jan J.T., Wu C.Y., Ma C., Wong C.H. Glycans on influenza hemagglutinin affect receptor binding and immune response. Proceedings of the National Academy of Sciences of the United States of America 2009, 106(43):18137-18142.
45. Wang Z., Mirza A.M., Li J., Mahon P.J., Iorio R.M. An oligosaccharide at the C-terminus of the F-specific domain in the stalk of the human parainfluenza virus 3 hemagglutinin-neuraminidase modulates fusion. Virus Research 2004, 99(2):177-185.
46. Watanabe M., Mishin V.P., Brown S.A., Russell C.J., Boyd K., Babu Y.S., Taylor G., Xiong X., Yan X., Portner A., Alymova I.V. Effect of hemagglutinin-neuraminidase inhibitors BCX 2798 and BCX 2855 on growth and pathogenicity of Sendai/human parainfluenza type 3 chimera virus in mice. Antimicrobial Agents and Chemotherapy 2009, 53(9):3942-3951.
47. Zhan X., Slobod K.S., Krishnamurthy S., Luque L.E., Takimoto T., Jones B., Surman S., Russell C.J., Portner A., Hurwitz J.L. Sendai virus recombinant vaccine expressing hPIV-3 HN or F elicits protective immunity and combines with a second recombinant to prevent hPIV-1, hPIV-3 and RSV infections. Vaccine 2008, 26(27-28):3480-3488.